ÂÜÀòÂÒÂ×

Bertrand Huguelet is a seasoned professional in the pharmaceutical industry, currently serving as Global Program Director at Ferring Pharmaceuticals since June 2023. Previously, Bertrand held the position of Director Make Asset Management at The Janssen Pharmaceutical Companies of Johnson & Johnson, where responsibilities included overseeing a USD 400 million CapEx portfolio and coordinating site master planning. Prior to this, Bertrand was Program Lead for the Lengnau Project at CSL Behring, managing a CHF 1.5 billion project, and Vice President of Engineering & Canada Site Head at Medicago, leading the construction of a CAD 400 million vaccine facility. Bertrand's extensive experience also includes significant roles at Merck, focusing on strategic projects and engineering, and earlier positions at Serono SA, Bracco, and Baxter. Bertrand holds a Master's degree in Chemistry from Université de Neuchâtel.